Clinical implications of circulating angiogenic factors in cancer patients

RTP Poon, ST Fan, J Wong - Journal of Clinical Oncology, 2001 - ascopubs.org
PURPOSE: Angiogenesis, a process fundamental to tumor growth, is regulated by
angiogenic factors. This article reviews prognostic and other clinical implications of …

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents

JM Cherrington, LM Strawn, LK Shawver - 2000 - Elsevier
Angiogenesis, the sprouting of new blood vessels, plays a role in diverse disease states
including cancer, diabetic retinopathy, age-related macular degeneration, rheumatoid …

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival

S Ugurel, G Rappl, W Tilgen… - Journal of clinical oncology, 2001 - ascopubs.org
PURPOSE: To determine the predictive value of the angiogenic serum factors angiogenin,
vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and …

The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal …

V Hanrahan, MJ Currie, SP Gunningham… - The Journal of …, 2003 - Wiley Online Library
Angiogenesis is essential for tumour growth and metastasis. It is controlled by angiogenic
factors, one of the most important being vascular endothelial growth factor (VEGF)‐A …

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin …

P Salven, A Orpana, L Teerenhovi… - Blood, The Journal of …, 2000 - ashpublications.org
High serum concentrations of vascular endothelial growth factor (S-VEGF) and basic
fibroblast growth factor (S-bFGF) are associated with unfavorable clinical characteristics in …

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor

P Salven, A Orpana, H Joensuu - Clinical cancer research, 1999 - AACR
Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific mitogen
and permeability factor. Malignant human tumors have been shown to produce VEGF …

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

C Li, B Guo, PB Wilson, A Stewart… - … Journal of Cancer, 2000 - Wiley Online Library
Abstract CD105 (endoglin), a receptor for transforming growth factor (TGF) β1 and β3 in
vascular endothelial cells, is highly up‐regulated in blood vessels of tissues where …

Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery

AJ Karayiannakis, KN Syrigos, A Polychronidis… - Annals of …, 2002 - journals.lww.com
Objective To evaluate the clinical usefulness of serum vascular endothelial growth factor
(VEGF) levels in gastric cancer patients. Summary Background Data Vascular endothelial …

Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma

RTP Poon, CPY Lau, ST Cheung, WC Yu, ST Fan - Cancer research, 2003 - AACR
Recent studies have suggested that serum levels of vascular endothelial growth factor
(VEGF) may provide useful prognostic information in patients with various types of cancers …

Das Infantile Hämangiom: Pathogenese und Wirkmechanismus von propranolol

A Rotter, ZNP de Oliveira - JDDG: Journal der Deutschen …, 2017 - Wiley Online Library
Das infantile Hämangiom (IH) ist der häufigste gutartige Tumor im Kindesalter. Die
Prävalenz beträgt 4% bis 10%. Es ist gekennzeichnet durch eine proliferative schnelle …